Study of South African Dialysis Patients
Study Details
An observational study to describe the treatment of anaemia in patients with chronic kidney disease, who are receiving dialysis treatment at selected study centres in South Africa.
Protocol Summary
Haemoglobin concentration
Timeframe: Reported as the mean of all available values for each 4-week period for the duration of the individual study period
Haemoglobin excursions
Timeframe: On a continuous basis over individual 15-month observation period up
Haemoglobin within range
Timeframe: On a continuous basis over individual 15-month observation period
Erythropoiesis stimulating agent (ESA) usage
Timeframe: On a continuous basis over individual 15-month observation period
ESA/Aranesp dose ratio
Timeframe: Day of commencement of Aranesp
Iron therapy use
Timeframe: On a continuous basis over individual 15-month observation period
Use of concomitant therapies: Immunosuppressants, cardiovascular medications, secondary hypoparathyroidism medications, anti-retroviral therapy
Timeframe: Usage recorded at each 12-week interval over the individual observation period
C-Reactive protein, albumin, transferrin saturation and serum ferritin
Timeframe: As available over individual 15-month observation period
Red cell transfusions
Timeframe: As occurring over individual 15-month observation period
Hospitalisation
Timeframe: As occurring over individual 15-month observation period
ESA usage
Timeframe: On a continuous basis over individual 15-month observation period
Iron therapy use
Timeframe: On a continuous basis over individual 15-month observation period
Iron therapy use
Timeframe: On a continuous basis over individual 15-month observation period
Iron therapy use
Timeframe: On a continuous basis over individual 15-month observation period
ESA usage
Timeframe: On a continuous basis over individual 15-month observation period
Red cell transfusions
Timeframe: As occurring over individual 15-month observation period
Hospitalisation
Timeframe: As occurring over individual 15-month observation period
Hospitalisation
Timeframe: As occurring over individual 15-month observation period